Sulphonylurea therapy doubles B-cell response to glucose in Type 2 diabetic patients

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Diabetologia

• Publication date

  1985-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00291069PMID 3936738
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of glipizide and food intake on the blood levels of glucose and insulin in diabetic patients.

  2009cited by this paper
• Hormonal and metabolic effects of chlorpropamide, glibenclamide and placebo in a cross-over study in diabetics not controlled by diet alone

  2004cited by this paper
• The Acute and Chronic Effects of Sulfonylurea Therapy in Type II Diabetic Subjects

  1984cited by this paper
• The Memphis and Atlanta Continuing Care Programs for Diabetes. II. Comparative Analyses of Demographic Characteristics, Treatment Methods, and Outcomes over a 9–10-year Follow-up Period

  1984cited by this paper
• Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.

  1984cited by this paper
• Potentiation of Insulin Action by a Sulfonylurea in Primary Cultures of Hepatocytes from Normal and Diabetic Rats

  1983cited by this paper
• The Long-term Effects of Chlorpropamide on Insulin, C-Peptide, and Proinsulin Secretion

  1982cited by this paper
• Relative contributions of insulin deficiency and insulin resistance in maturity-onset diabetes.

  1982cited by this paper
• Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose.

  1982cited by this paper
• Physician-Patient Communication in Chronic Illness

  1981cited by this paper
• Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.

  1981cited by this paper
• In vitro effects of a sulfonylurea on insulin action in adipocytes. Potentiation of insulin-stimulated hexose transport.

  1981cited by this paper
• Hormonal and metabolic effects of chlorpropamide, glibenclamide and placebo in a cross-over study in diabetics not controlled by diet alone

  1981cited by this paper
• Selective potentiation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide.

  1981cited by this paper
• Insulin secretion in diabetes mellitus.

  1981cited by this paper
• Potentiation of Insulin Secretion to Nonglucose Stimuli in Normal Man by Tolbutamide

  1980cited by this paper
• SULFONYLUREAS INCREASE THE NUMBER OF INSULIN RECEPTORS

  1979cited by this paper
• Glucose clamp technique: a method for quantifying insulin secretion and resistance.

  1979cited by this paper
• Maintenance of Basal Plasma Glucose and Insulin Concentrations in Maturity-Onset Diabetes

  1979cited by this paper
• Kinetics of Human C-peptide in Man

  1978cited by this paper
• Sulphonylureas increase the number of insulin receptors

  1978cited by this paper
• Basal normoglycemia attained with chlorpropamide in mild diabetes.

  1978cited by this paper
• DIABETES: THE QUEST FOR BASAL NORMOGLYCÆMIA

  1977cited by this paper
• The Effect of Chronic Oral Antidiabetic Therapy on Insulin and Glucagon Responses to a Meal

  1977cited by this paper
• Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamide

  1977cited by this paper
• Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients.

  1976cited by this paper
• Insulin rather than glucose homoeostasis in the pathophysiology of diabetes.

  1976cited by this paper
• Letter: Clonidine withdrawal and blockade.

  1976cited by this paper
• Insulin‐stimulated entry of glucose into muscle in vivo as a major factor in the regulation of blood glucose.

  1975cited by this paper
• Insulin‐stimulated entry of glucose into muscle in vivo as a major factor in the regulation of blood glucose.

  1975cited by this paper
• Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.

  1974cited by this paper
• A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties.

  1972cited by this paper
• Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels.

  1972cited by this paper
• Measurement of the insulin delivery rate in man.

  1971cited by this paper
• Endocrine and Metabolic Effects of Glybenclamide: Evidence for an Extrapancreatic Mechanism of Action

  1971cited by this paper
• Effect of Chlorpropamide on Serum Glucose and Immunoreactive Insulin Concentrations in Patients with Maturity-onset Diabetes Mellitus

  1967cited by this paper
• SKIN DISEASE AND THE BOWEL.

  1965cited by this paper
• Failure of Prolonged Sulfonylurea Administration to Enhance Insulogenic Response to Glycemic Stimulus

  1965cited by this paper

• Hypoglycaemic effects of glimepiride in sulfonylurea receptor 1 deficient rat

  2018cites this paper
• Within-class differences of the sulfonylureas should be accounted for. Reply to Schrijnders D, Kleefstra N and Landman GWD [letter]

  2015cites this paper
• The effect of glibenclamide on insulin secretion at normal glucose concentrations

  2014cites this paper
• Expansion of the Homeostasis Model Assessment of β-Cell Function and Insulin Resistance to Enable Clinical Trial Outcome Modeling Through the Interactive Adjustment of Physiology and Treatment Effects: iHOMA2

  2013cites this paper
• Chemical screening and antihyperglycemic property of Cleome droserifolia ethanol extract

  2013cites this paper
• Dietary Fibre Improves First-phase Insulin Secretion in Overweight Individuals

  2012cites this paper
• Repaglinide treatment amplifies first‐phase insulin secretion and high‐frequency pulsatile insulin release in Type 2 diabetes

  2005cites this paper
• Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study

  2004cites this paper
• The GLP-1 derivative NN2211 restores beta-cell sensitivity to glucose in type 2 diabetic patients after a single dose.

  2003cites this paper
• Pharmacokinetics of tolbutamide after oral administration to rabbits with folate-lnduced renal failure

  2003cites this paper
• [Differences in insulin secretion facilitate the differential diagnosis of insulinoma and factitious hypoglycaemia].

  2002cites this paper
• Comparison of the Effects of Three Sulfonylureas on in vivo Insulin Action

  2001cites this paper
• Effects and serum levels of glibenclamide and its active metabolites in patients with type 2 diabetes

  2001cites this paper
• Gliclazide Mainly Affects Insulin Secretion in Second Phase of Type 2 Diabetes Mellitus

  2001cites this paper
• Pharmacodynamics and pharmacokinetics of intravenous glibenclamide in Caucasian and Chinese patients with type-2 diabetes

  2000cites this paper
• The Use of Sulphonylureas in the Elderly

  1999cites this paper
• Effects of gliclazide versus metformin on the clinical profile and lipid peroxidation markers in type 2 diabetes.

  1999cites this paper
• Effect of gliclazide treatment on insulin secretion and beta-cell mass in non-insulin dependent diabetic Goto-Kakisaki rats.

  1998cites this paper
• Changes in Amylin and Amylin-Like Peptide Concentrations ana (β-Cell Function in Response to Sulfonylurea or Insulin Therapy in NIDDM

  1998cites this paper
• Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM

  1997cites this paper
• Beta Cell Response to Oral Glimepiride Administration During and Following a Hyperglycaemic Clamp in NIDDM Patients

  1997cites this paper
• From sand rats to diabetic patients: is non-insulin-dependent diabetes mellitus a disease of the beta cell?

  1997cites this paper
• Notes on the GENNID Study

  1996cites this paper
• No deterioration of insulin secretion by the potassium channel opener pinacidil in essential hypertension.

  1996cites this paper
• Normalization of Insulin Responses to Glucose by Overnight Infusion of Glucagon-Like Peptide 1 (7–36) Amide in Patients With NIDDM

  1996cites this paper
• Insulin secretion in obese and non-obese NIDDM.

  1995cites this paper
• Prevention of Complications in Non-Insulin-Dependent Diabetes Mellitus (NIDDM)

  1995cites this paper
• Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

  1995cites this paper
• Lack of effect of CS-045, a new antidiabetic agent, on insulin secretion in the remnant pancreas after 90% pancreatectomy in rats.

  1995cites this paper
• Extrapancreatic effects of sulfonylureas--a comparison between glimepiride and conventional sulfonylureas.

  1995cites this paper
• DIACATOR: simulation of metabolic abnormalities of type II diabetes mellitus by use of a personal computer.

  1994cites this paper
• Comparative dose-related time-action profiles of glibenclamide and a new non-sulphonylurea drug, AG-EE 623 ZW, during euglycaemic clamp in healthy subjects

  1994cites this paper
• Comparative Tolerability Profiles of Oral Antidiabetic Agents

  1994cites this paper
• Do adipocytes contain high affinity sulfonylurea receptors.

  1994cites this paper
• Tablet and Insulin Therapy in Type 2 Diabetes in the Elderly

  1994cites this paper
• Long-Term Randomized Placebo-Controlled Double-Blind Therapeutic Comparison of Glipizide and Glyburide: Glycemic control and insulin secretion during 15 months

  1994cites this paper
• Association of low birth weight with beta cell function in the adult first degree relatives of non-insulin dependent diabetic subjects.

  1993cites this paper
• The Effect of Glyburide on β-Cell Sensitivity to Glucose-Dependent Insulinotropic Polypeptide

  1993cites this paper
• Effect of using safer blood products on prevalence of HIV infection in haemophilic Canadians. Canadian Hemophilia Clinic Directors Group.

  1993cites this paper
• Does glibenclamide influence the clearance of insulin and glucose uptake in patients with type 2 diabetes mellitus?

  1993cites this paper
• Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone

  1992cites this paper
• Sulfonylureas in NIDDM

  1992cites this paper
• Chronic exposure to glibenclamide impairs insulin secretion in isolated rat pancreatic islets

  1991cites this paper
• Effect of 6 months' gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial CSII-induced normoglycemia.

  1991cites this paper
• Effect of 6-month gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial continuous subcutaneous insulin infusion-induced normoglycemia.

  1991cites this paper
• Dose-Dependent Effects of Glyburide on Insulin Secretion and Glucose Uptake in Humans

  1991cites this paper
• Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.

  1991cites this paper
• [Physiopathology of non-insulin-dependent diabetes: current data and therapeutic consequences].

  1990cites this paper
• Insulin Use in NIDDM: Rationale Based on Pathophysiology of Disease

  1990cites this paper
• Pharmacokinetic-Pharmacodynamic Relationships of Oral Hypoglycaemic Agents

  1989cites this paper
• Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with Type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin

  1989cites this paper
• Sulphonylureas in the treatment of non-insulin-dependent diabetes.

  1989cites this paper
• Unbiased and Flexible Iterative Computer Program to Achieve Glucose Clamping

  1989cites this paper
• Oral hypoglycemic agents.

  1989cites this paper
• The Natural History of Insulin Secretion in Type 1 Diabetes

  1989cites this paper
• Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy.

  1989cites this paper
• Impaired beta-cell responses improve when fasting blood glucose concentration is reduced in non-insulin-dependent diabetes.

  1988cites this paper
• Pathogenesis of NIDDM--a disease of deficient insulin secretion.

  1988cites this paper
• The glucose stimulus-response curve of the beta-cell in physically trained humans, assessed by hyperglycemic clamps.

  1988cites this paper
• The Relationship Between the Pharmacokinetics and Pharmacodynamic Effects of Oral Hypoglycaemic Drugs

  1987cites this paper
• The use of oral hypoglycaemic agents in the treatment of diabetes mellitus

  1987cites this paper
• Insulin secretion and insulin sensitivity defects are a common feature of mild, clinically homogeneous, recently diagnosed type II (Non-insulin-dependent) diabetics

  1986cites this paper